Search

everythinglearnresearchcommunity

for

Search:↓

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Hair follicles prevent NK cell attacks to avoid hair loss.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Different types of stem cells and their environments are key to skin repair and maintenance.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Vitiligo and alopecia areata may have similar causes despite their differences.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Hair follicle stem cells have greater longevity and adhesion, while transit-amplifying cells are more mobile.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Understanding EGFR roles could lead to new hair loss treatments.

The document suggests that the traditional understanding of hair growth cycles and alopecia may be inaccurate and that blood supply plays a significant role in hair growth and loss.

Laser hair removal before genital surgery can prevent complications and improve patient satisfaction.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

ILC1-like cells can independently cause alopecia areata.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Pigmented casts are common in several hair loss conditions and can help diagnose specific types of alopecia.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

A simplified method was introduced to diagnose most hair loss types by examining the patient's history and scalp, with some cases needing further tests.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Some vitamins and minerals are important for preventing hair loss, but treating hair loss with them without a known deficiency is not proven effective.